Pluri Inc. — Director's Dealing 2014

Sep 17, 2014

Submission Proof - \sbs2011\edgar\EDGAR Filing\Other Filers\ABERMAN ZAMI\Pluristem Therapeutics Inc\1415555\a1415555.gfp

17/9/2014

FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Check this box if no longer STATEMENT OF CHANGES IN BENEFICIAL subject to Section 16. Form 4

or Form 5 obligations may OWNERSHIP continue. See Instruction 1(b).

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: December 31, 2014 Estimated average burden hours 0.5 per response

1. Name and Address of Reporting Person[*] 2. Issuer Name and Ticker or Trading Symbol 5. Relationship of Reporting Person(s) to Issuer Aberman Zami 0001344740 PLURISTEM THERAPEUTICS INC [ (Check all applicable) PSTI ] X Director 10% Owner (Last) (First) (Middle) X Officer (give titlebelow) Other (specifybelow) 3. Date of Earliest Transaction (Month/Day/Year) 46 HATAPUZ ST. 09/16/2014 CEO & Chairman (Street) 4. If Amendment, Date of Original Filed 6. Individual or Joint/Group Filing (Check Applicable (Month/Day/Year) Line) TELMOND L3 40600 X Form filed by One Reporting Person Form filed by More than One Reporting Person (City) (State) (Zip) Table I – Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) 2. Transaction 2A. Deemed 3. 4. Securities Acquired (A) or 5. Amount of 6. Ownership 7. Nature Date Execution Date, if Transaction Disposed Of (D) (Instr. 3, 4 and Securities Form: Direct of Indirect (Month/Day/Year) any Code 5) Beneficially (D) or Indirect Beneficial (Month/Day/Year) (Instr. 8) Owned Following (I) (Instr. 4) Ownership Reported (Instr. 4) Code V Amount (A) or Price Transaction(s) (D) (Instr. 3 and 4) Common Stock 09/16/2014 P 15,000 A $2.84 1,745,298 D

Table II – Derivative Securities Acquired, Disposed of, or Beneficially Owned

(e.g., puts, calls, warrants, options, convertible securities)

==> picture [526 x 119] intentionally omitted <==

----- Start of picture text -----

1. Title of 2. 3. Transaction 3A. Deemed 4. 5. 6. Date Exercisable and 7. Title and 8. Price of 9. Number of 10. 11. NatureDerivative Conversion Date Execution Date, if Transaction Number Expiration Date Amount of Derivative Derivative Ownership of IndirectSecurity or Exercise (Month/Day/Year) any Code (Instr. of (Month/Day/Year) Securities Security Securities Form: Beneficial(Instr. 3) Price of (Month/Day/Year) 8) Derivative Underlying (Instr. 5) Beneficially Direct (D) OwnershipDerivative Securities Derivative Owned or Indirect (Instr. 4)Security Acquired Security (Instr. Following (I) (Instr.(A) or 3 and 4) Reported 4)Disposed Transaction(s)of (D) (Instr. 4)(Instr. 3,4and 5)AmountorNumberDate Expiration ofCode V (A) (D) Exercisable Date Title Shares----- End of picture text -----

Explanation of Responses:

Remarks:

/s/ Zami Aberman

• ** Signature of Reporting Person

09/17/2014

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

file://sbs2011/edgar/EDGAR%20Filing/Other%20Filers/ABERMAN%20ZAMI/Pluristem%20Therapeutics%20Inc/1415555/proof.htm

2/2